Gruppo Oncologico Italiano Di Ricerca Clinica

This study looks at 100 people with a specific type of lung cancer (EGFR-mutated NSCLC) whose cancer came back during or after treatment with the drug osimertinib. Researchers want to find out what new genetic changes appear when the cancer returns. This is an observational study…

This observational study will track 50 people with advanced non-small cell lung cancer (NSCLC) in Italy to see how common HER2 mutations are and how doctors currently treat them. Participants will be followed for one year. The goal is to understand real-world care, not to test a …